|
Volumn 43, Issue 3, 2001, Pages 202-206
|
Fetal valproate syndrome and autism: Additional evidence of an association
a,g b c d e f |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
PHENYTOIN;
VALPROIC ACID;
ARNOLD CHIARI MALFORMATION;
ARTICLE;
AUTISM;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MALFORMATION;
CHILD;
CLINICAL ARTICLE;
CLINICAL FEATURE;
COGNITIVE DEFECT;
COMMUNICATION DISORDER;
CONDUCTION DEAFNESS;
DEVELOPMENTAL DISORDER;
DISEASE ASSOCIATION;
DRUG EXPOSURE;
FETAL VALPROATE SYNDROME;
FETOTOXICITY;
GENETIC DISORDER;
GROWTH RETARDATION;
HEARING LOSS;
HUMAN;
MICROCEPHALY;
PHENOTYPE;
POSTNATAL DEVELOPMENT;
PRIORITY JOURNAL;
RISK FACTOR;
SUBGLOTTIC STENOSIS;
TERATOGENICITY;
TRACHEOMALACIA;
AUTISTIC DISORDER;
CHILD;
CHILD, PRESCHOOL;
DEVELOPMENTAL DISABILITIES;
EPILEPSY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFANT;
INFANT, NEWBORN;
MALE;
PREGNANCY;
PREGNANCY COMPLICATIONS;
SYNDROME;
VALPROIC ACID;
|
EID: 0035084438
PISSN: 00121622
EISSN: None
Source Type: Journal
DOI: 10.1017/S001216220100038X Document Type: Article |
Times cited : (327)
|
References (30)
|